Top Clinical Trials companies in Japan by Return on Capital Employed (ROCE)
Japan
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
27.00%
|
Dec. 31, 2023 | USD 43.39 | 5.16% |
|
Japan |
|
| 2 |
25.42%
|
Dec. 31, 2023 | USD 21.58 | 0.31% |
|
Japan |
|
| 3 |
16.73%
|
March 31, 2024 | USD 11.15 | -1.27% |
|
Japan |
|
| 4 |
15.63%
|
Sept. 30, 2024 | USD 9.46 | -2.05% |
|
Japan |
|
| 5 |
15.55%
|
March 31, 2024 | USD 14.75 | -0.46% |
|
Japan |
|
| 6 |
13.49%
|
March 31, 2024 | USD 10.95 | -0.53% |
|
Japan |
|
| 7 |
11.36%
|
March 31, 2024 | USD 9.47 | -2.44% |
|
Japan |
|
| 8 |
11.19%
|
Dec. 31, 2023 | USD 13.83 | -0.63% |
|
Japan |
|
| 9 |
11.16%
|
March 31, 2024 | USD 10.09 | 0.15% |
|
Japan |
|
| 10 |
10.91%
|
Dec. 31, 2023 | USD 14.95 | -1.71% |
|
Japan |
|
| 11 |
10.17%
|
March 31, 2024 | USD 3.56 | -3.55% |
|
Japan |
|
| 12 |
9.02%
|
March 31, 2024 | USD 15.32 | -0.42% |
|
Japan |
|
| 13 |
8.71%
|
March 31, 2024 | USD 17.95 | -0.66% |
|
Japan |
|
| 14 |
6.63%
|
June 30, 2024 | USD 8.09 | -0.35% |
|
Japan |
|
| 15 |
6.29%
|
March 31, 2024 | USD 2.22 | 6.19% |
|
Japan |
|
| 16 |
5.95%
|
March 31, 2024 | USD 25.51 | -0.96% |
|
Japan |
|
| 17 |
5.36%
|
March 31, 2024 | USD 9.48 | -0.72% |
|
Japan |
|
| 18 |
2.73%
|
March 31, 2024 | USD 2.10 | -1.79% |
|
Japan |
|
| 19 |
1.64%
|
March 31, 2024 | USD 9.76 | -1.53% |
|
Japan |
|
| 20 |
1.15%
|
March 31, 2024 | USD 27.12 | 0.10% |
|
Japan |
|
| 21 |
-0.34%
|
March 31, 2024 | USD 0.72 | 0.32% |
|
Japan |
|
| 22 |
-4.43%
|
Dec. 31, 2023 | USD 2.56 | -2.54% |
|
Japan |
|
| 23 |
-5.85%
|
Dec. 31, 2023 | USD 6.24 | -4.05% |
|
Japan |
|
| 24 |
-9.74%
|
June 30, 2024 | USD 1.03 | -3.60% |
|
Japan |
|
| 25 |
-16.24%
|
March 31, 2024 | USD 5.69 | -0.47% |
|
Japan |
|
| 26 |
-18.85%
|
March 31, 2024 | USD 0.90 | -0.59% |
|
Japan |
|
| 27 |
-28.37%
|
Dec. 31, 2023 | USD 1.90 | -2.24% |
|
Japan |
|
| 28 |
-58.63%
|
Dec. 31, 2023 | USD 0.24 | -0.59% |
|
Japan |
|
| 29 |
-109.61%
|
Jan. 31, 2024 | USD 4.64 | 0.11% |
|
Japan |
|
| 30 |
-116.24%
|
Dec. 31, 2023 | USD 3.68 | -3.46% |
|
Japan |
|
| 31 |
-220.77%
|
March 31, 2024 | USD 0.17 | -10.87% |
|
Japan |
Frequently Asked Questions
-
Which Clinical Trials company in Japan has the highest Return on Capital Employed (ROCE) ?
The Clinical Trials company in Japan with the highest Return on Capital Employed (ROCE) is Chugai Pharmaceutical Co., Ltd. (Tokyo Stock Exchange: 4519.T) at 27.00%.
-
Which Clinical Trials company in Japan has the lowest Return on Capital Employed (ROCE) ?
The Clinical Trials company in Japan with the lowest Return on Capital Employed (ROCE) is OncoTherapy Science, Inc. (Tokyo Stock Exchange: 4564.T) at -220.77%.
-
What are the top 10 Clinical Trials companies in Japan by Return on Capital Employed (ROCE) ?
The top 10 Clinical Trials companies in Japan by Return on Capital Employed (ROCE) are Chugai Pharmaceutical Co., Ltd., GNI Group Ltd., WDB Holdings Co., Ltd., Fuji Pharma Co., Ltd., Shionogi & Co., Ltd., Shin Nippon Biomedical Laboratories, Ltd., Qol Holdings Co., Ltd., PeptiDream Inc., Santen Pharmaceutical Co., Ltd. and Kyowa Kirin Co., Ltd..
-
What are the bottom 10 Clinical Trials companies in Japan by Return on Capital Employed (ROCE) ?
The bottom 10 Clinical Trials companies in Japan by Return on Capital Employed (ROCE) are OncoTherapy Science, Inc., Oncolys BioPharma Inc., SanBio Company Limited, Solasia Pharma K.K., Carna Biosciences, Inc., NanoCarrier Co., Ltd., Cytori Cell Research Institute, Inc., Soiken Holdings Inc., Nxera Pharma Co., Ltd. and RaQualia Pharma Inc..
